Johnson & Johnson (JNJ) vs Pfizer Inc. (PFE)
PFE leads on 8 of 15 compared metrics.
A side-by-side comparison of Johnson & Johnson and Pfizer Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — JNJ vs PFE
growth of $100 · last 30yJNJ +885.6%PFE +128.5%JNJ compounded faster
JNJ PFE
JNJ vs PFE: by the numbers
- •JNJ is the larger company ($579.83B vs $149.38B market cap).
- •PFE trades at the lower earnings multiple (20.01 vs 27.85 P/E).
- •JNJ converts more revenue to profit (21.83% vs 11.83% net margin).
- •PFE grew revenue faster over the past five years (8.22% vs 2.99% CAGR).
- •PFE pays the higher dividend yield (6.56% vs 2.18%).
Which is better, JNJ or PFE?
Metric tally: JNJ 7 · PFE 8It depends on what you're optimizing for:
ValuePFE(lower P/E)
GrowthPFE(faster 5Y revenue CAGR)
IncomePFE(higher dividend yield)
QualityJNJ(higher ROIC)
Valuation
| Metric | JNJ | PFE |
|---|---|---|
| P/E ratio | 27.85 | 20.01● |
| Forward P/E | 18.87 | 9.25● |
| P/S ratio | 6.11 | 2.37● |
| P/B ratio | 7.25 | 1.67● |
| PEG ratio | 0.21 | — |
| EV / EBITDA | 18.71 | 12.72● |
| FCF yield | 3.02% | 6.31%● |
Profitability
| Metric | JNJ | PFE |
|---|---|---|
| Gross margin | 69.12% | 69.35% |
| Operating margin | 26.87%● | 23.45% |
| Net margin | 21.83%● | 11.83% |
| ROE | 25.92%● | 8.31% |
| ROIC | 13.71%● | 8.84% |
Dividends
| Metric | JNJ | PFE |
|---|---|---|
| Dividend yield | 2.18% | 6.56%● |
| Payout ratio | 47.51% | 126.47% |
Growth (annualized)
| Metric | JNJ | PFE |
|---|---|---|
| Revenue CAGR (5Y) | 2.99% | 8.22%● |
| EPS CAGR (5Y) | 11.51%● | -3.78% |
| FCF CAGR (5Y) | -2.38%● | -3.79% |
| Total return CAGR (5Y) | 10.93%● | -3.33% |
Frequently asked
- Which is better, JNJ or PFE?
- It depends on your goal. value: PFE (lower P/E); growth: PFE (faster 5Y revenue CAGR); income: PFE (higher dividend yield); quality: JNJ (higher ROIC). Across all compared metrics, PFE leads 8 to 7.
- Is JNJ or PFE cheaper?
- On trailing earnings, PFE is cheaper: JNJ trades at a 27.85 P/E and PFE at 20.01.
- Which has grown faster, JNJ or PFE?
- Over the past five years, PFE grew revenue faster — JNJ at a 2.99% CAGR versus PFE at 8.22%.
- Does JNJ or PFE pay a bigger dividend?
- JNJ yields 2.18% and PFE yields 6.56% based on trailing dividends and the latest price.
- Is JNJ or PFE more profitable?
- JNJ runs the higher net margin — JNJ at 21.83% versus PFE at 11.83%.
- Which has been the better investment, JNJ or PFE?
- Over the past 10-year, JNJ delivered the higher annualized total return — JNJ at 10.46% versus PFE at 2.13%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Johnson & Johnson P/E ratioPfizer P/E ratioJohnson & Johnson dividend yieldPfizer dividend yieldJohnson & Johnson ROEPfizer ROEJohnson & Johnson operating marginPfizer operating marginJohnson & Johnson revenue growthPfizer revenue growthJohnson & Johnson free cash flowPfizer free cash flow
Johnson & Johnson & Pfizer appear in these rankings
Related comparisons
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.